Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The innate immune response in the central nervous system (CNS) is implicated as both beneficial and detrimental to health. Integral to this process are microglia, the resident immune cells of the CNS. Microglia express a wide variety of pattern-recognition receptors, such as Toll-like receptors, that detect changes in the neural environment. The activation of microglia and the subsequent proinflammatory response has become increasingly relevant to synucleinopathies, including Parkinson's disease the second most prevalent neurodegenerative disease. Within these diseases there is evidence of the accumulation of endogenous α-synuclein that stimulates an inflammatory response from microglia via the Toll-like receptors. There have been recent developments in both new and old pharmacological agents designed to target microglia and curtail the inflammatory environment. This review will aim to delineate the process of microglia-mediated inflammation and new therapeutic avenues to manage the response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 1×
“Pathogen-associated molecular patterns (PAMPs), which include various bacterial and viral components, are the exogenous molecules that PRRs, such as RIG-I-like receptors, NOD-like receptors, and TLRs respond to (as reviewed by; Chen and Nunez, 2010).”
BackgroundMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 3×
“A prototypical example of TLR2 signaling potentiation is miR-155, which is upregulated with TLR4 activation via both the AP-1 (O’Connell et al., 2007; Yin et al., 2008) and NF-κB pathways (Bala et al.”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · cited 1×
“The extracellular αSyn can then be endocytosed by neighboring neurons and this neuron-to-neuron transmission has been shown to be neurotoxic (Desplats et al., 2009).”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Neurons express and release αSyn into the surrounding environment (Lee et al., 2005; Kim C. et al., 2016) and microglia recognize this with Toll-like receptors (TLRs) and subsequently produce a proinflammatory response (Zhang et al., 2005; West et al., 2006; Su et al., 2008; Vezzani et al., 2011).”
BackgroundIn vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 2×
“…state can be measured with [11C](R)-PK11195 positron emission tomography (PET) imaging and such studies demonstrate progressive microglial activation during early pathogenesis, followed by sustained microglial activation during mid to late disease stages (Gerhard et al., 2006a; Ouchi et al., 2009).”
BackgroundMethodMicroglial brain region-dependent diversity and selective regional sensitivities to aging
Grabert, K., Michoel, T., Karavolos, M. H., Clohisey, S., Baillie, J. K., Stevens, M. P., Freeman, T. C., Summers, K. M., & McColl, B. W. (2016) · Nature Neuroscience · doi:10.1038/nn.4222 · Cited by 1,151
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 2×
“In the MyD88-dependent pathway (Figure 1), death domain interactions mediate intracellular signal transduction in a sequential manner from MyD88 to the phosphorylation of interleukin-1 receptor-associated kinase (IRAK) 4, then to IRAK1 and IRAK2 (Lin et al., 2010).”
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
A microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040 · cited 20×
“Calcitriol, the active form of vitamin D, represses miR-155 after LPS stimulation and reduces NF-κB nuclear translocation (Chen et al., 2013b).”
BackgroundInfluentialKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · cited 3×
“…pathogenesis. αSyn or Pam3CSK4 activation of TLR2 in BV-2 microglia (Béraud et al., 2013), primary mouse microglia (Babcock et al., 2006; Downer et al., 2013; Kim et al., 2013; Daniele et al., 2015), and human microglia leads to the MyD88-dependent release of TNF-α and IL-1β (Dzamko et al., 2016).”
BackgroundMapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 1×
“…Baba et al., 1998; Braak et al., 2003). αSyn garnered significant interest after a number of mutations, namely A53T and A30P, were found in familial cases of PD (Polymeropoulos et al., 1996, 1997; Krüger et al., 1998; Athanassiadou et al., 1999; Singleton et al., 2003; Emmanouilidou et al., 2011).”
BackgroundTakeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749 · cited 1×
“…neuron loss is correlated with microglial upregulation of inducible nitric oxide synthase (iNOS) and the release of nitric oxide (NO) (Knott et al., 2000; Gao et al., 2008), tumor necrosis factor α (TNFα) (McCoy et al., 2006; Takeuchi et al., 2006), and interleukin (IL)−1β (Ferrari et al., 2006).”
BackgroundActivation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738 · cited 1×
“The proinflammatory response from microglia generates reactive oxygen species (ROS), which in turn stimulates the Nrf2/ARE pathway as a late phase response to control microglial activation (Li et al., 2008; Innamorato et al., 2009).”
BackgroundLiu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697 · cited 1×
“The Nrf2/ARE and the NF-κB pathways cross regulate one another, which provides a unique target for managing microglial responses to αSyn and proinflammatory cytokines (Innamorato et al., 2008; Liu et al., 2008).”
BackgroundToll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634 · cited 1×
“…et al. demonstrated that TLR4 contributes to early neuropathic pain associated with nerve transection suggesting that while these receptors are conserved mediators of pathogen recognition and removal, TLRs also have the potential to accelerate neurodegeneration upon activation (Tanga et al., 2005).”
BackgroundCD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · cited 2×
“Similarly, TLR2 (Jana et al., 2008), TLR4, and CD14 are implicated in Alzheimer’s disease as integral receptors for fibrillar Aβ recognition (Reed-Geaghan et al., 2009).”
BackgroundAn activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP
Wayman, G. A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.-Y. M., Marks, D., Obrietan, K., Soderling, T. R., Goodman, R. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803072105 · Cited by 559 · cited 2×
“They act as translational repressors (Baek et al., 2008) and are involved in development (Wightman et al., 1991, 1993; Vo et al., 2005), neurogenesis (Krichevsky et al., 2003), and plasticity (Wayman et al., 2008).”
BackgroundA randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
Rice, T. W., Wheeler, A. P., Bernard, G. R., Vincent, J.-L., Angus, D. C., Aikawa, N., Demeyer, I., Sainati, S., Amlot, N., Cao, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e7c5c9 · Cited by 512
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · cited 1×
“…dopaminergic neuron loss is correlated with microglial upregulation of inducible nitric oxide synthase (iNOS) and the release of nitric oxide (NO) (Knott et al., 2000; Gao et al., 2008), tumor necrosis factor α (TNFα) (McCoy et al., 2006; Takeuchi et al., 2006), and interleukin (IL)−1β (Ferrari…”
BackgroundSynuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 3×
“Neurons express and release αSyn into the surrounding environment (Lee et al., 2005; Kim C. et al., 2016) and microglia recognize this with Toll-like receptors (TLRs) and subsequently produce a proinflammatory response (Zhang et al., 2005; West et al., 2006; Su et al., 2008; Vezzani et al., 2011).”
BackgroundSelf-citationLiu, G., Friggeri, A., Yang, Y., Park, Y.-J., Tsuruta, Y., & Abraham, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901216106 · Cited by 438
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
miR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death
Neher, J. J., Neniskyte, U., Zhao, J.-W., Bal-Price, A., Tolkovsky, A. M., & Brown, G. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003600 · Cited by 373 · cited 1×
“And in an alternative approach to microglial inhibition, cyclic Arginine-Guanine-Aspartic Acid (cRGD), has been used to repress autophagy, which in turn reduces neuronal loss when co-cultured with TLR2-activated microglia (Neher et al., 2011).”
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372
Cardoso, A. L., Guedes, J. R., Pereira de Almeida, L., & Pedroso de Lima, M. C. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03514.x · Cited by 336 · cited 5×
“SOCS1 also plays an inhibitory role restricting cytokine production through interactions with IRAK1 or TRAF6 (Nakagawa et al., 2002; West et al., 2006; Cardoso et al., 2012).”
BackgroundInfluentialNovel cross-talk within the IKK family controls innate immunity
Clark, K., Peggie, M., Plater, L., Sorcek, R. J., Young, E. R. R., Madwed, J. B., Hough, J., McIver, E. G., & Cohen, P. (2011) · Biochemical Journal · doi:10.1042/bj20101701 · Cited by 326 · cited 9×
“K1L and N1L are two additional vaccinia virus proteins that inhibit IκBα degradation and the downstream kinases TBK1 and IKKs respectively (Aravalli et al., 2008).”
BackgroundInfluentialDaniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303 · cited 8×
“Rather, 24 h after αSyn stimulation microglia also produce IL-10, an anti-inflammatory cytokine (Daniele et al., 2015).”
BackgroundResultInfluentialSelf-citationBrun, P., Giron, M. C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., Banzato, S., Grillo, A. R., Spagnol, L., De Caro, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.047 · Cited by 300 · cited 1×
“TLR2 is expressed in NT2-N teratocarcinoma cells (Lafon et al., 2006), SH-SY5Y neuroblastoma cell (Kim et al., 2015), primary mouse neurons (Downer et al., 2013), and human neurons in the CNS (Dzamko et al., 2016) and ENS (Brun et al., 2013).”
BackgroundJang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281 · cited 1×
“This ER/Golgi-independent exocytotic mechanism is exacerbated under cellular stress conditions, such as proteasome inhibition (Jang et al., 2010).”
BackgroundDzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., Fu, Y., & Halliday, G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1648-8 · Cited by 273
Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272
Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254
Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., & Pitossi, F. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.013 · Cited by 235 · cited 1×
“…neuron loss is correlated with microglial upregulation of inducible nitric oxide synthase (iNOS) and the release of nitric oxide (NO) (Knott et al., 2000; Gao et al., 2008), tumor necrosis factor α (TNFα) (McCoy et al., 2006; Takeuchi et al., 2006), and interleukin (IL)−1β (Ferrari et al., 2006).”
BackgroundCall off the dog(ma): M1/M2 polarization is concurrent following traumatic brain injury
Morganti, J. M., Riparip, L.-K., & Rosi, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148001 · Cited by 229 · cited 1×
“But more recent investigation has begun to reorganize this nomenclature in favor of a continuum of morphological characteristics, each of which being representative of a particular microglial function (as reviewed by; Hanisch, 2013; Kim C. C. et al., 2016; Morganti et al., 2016; Ransohoff, 2016).”
BackgroundDettmer, U., Newman, A. J., Luth, E. S., Bartels, T., & Selkoe, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403311 · Cited by 221 · cited 1×
“…native conformation of αSyn have led to two proposals; one provides support for a stable tetramer formation that is ostensibly lost after cell lysis (Dettmer et al., 2013) and the other body of evidence shows αSyn to be an intrinsically disordered protein (IDP) with an ill-defined secondary…”
BackgroundFunctional diversity of microglia – how heterogeneous are they to begin with?
Hanisch, U.-K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00065 · Cited by 195
In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy
Gerhard, A., Trender‐Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P., & Brooks, D. J. (2006) · Movement Disorders · doi:10.1002/mds.20668 · Cited by 171 · cited 2×
“…state can be measured with [11C](R)-PK11195 positron emission tomography (PET) imaging and such studies demonstrate progressive microglial activation during early pathogenesis, followed by sustained microglial activation during mid to late disease stages (Gerhard et al., 2006a; Ouchi et al., 2009).”
BackgroundMethodAssessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
Emmanouilidou, E., Elenis, D., Papasilekas, T., Stranjalis, G., Gerozissis, K., Ioannou, P. C., & Vekrellis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022225 · Cited by 163 · cited 2×
“…Baba et al., 1998; Braak et al., 2003). αSyn garnered significant interest after a number of mutations, namely A53T and A30P, were found in familial cases of PD (Polymeropoulos et al., 1996, 1997; Krüger et al., 1998; Athanassiadou et al., 1999; Singleton et al., 2003; Emmanouilidou et al., 2011).”
BackgroundDrouin-Ouellet, J., St-Amour, I., Saint-Pierre, M., Lamontagne-Proulx, J., Kriz, J., Barker, R. A., & Cicchetti, F. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu103 · Cited by 153 · cited 2×
“Additional support for a role of TLR2-mediated inflammation in Parkinson’s disease comes from Droiun-Ouellet et al., where TLR2 expression was increased in circulating monocytes of Parkinson’s patients (Drouin-Ouellet et al., 2015).”
BackgroundSaba, R., Gushue, S., Huzarewich, R. L. C. H., Manguiat, K., Medina, S., Robertson, C., & Booth, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030832 · Cited by 151 · cited 3×
“…et al., 2014), PBMCs (Nahid et al., 2013), oligodendrocytes (Santra et al., 2014), and microglia using TLR2, TLR4, and prion-induced mechanisms (Saba et al., 2012). miR-146a inhibits the translation of TRAF6, Frontiers in Pharmacology | www.frontiersin.org 6 May 2018 | Volume 9 | Article…”
BackgroundBrain trauma elicits non-canonical macrophage activation states
Kim, C. C., Nakamura, M. C., & Hsieh, C. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0581-z · Cited by 149
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Kim, C., Rockenstein, E., Spencer, B., Kim, H.-K., Adame, A., Trejo, M., Stafa, K., Lee, H.-J., Lee, S.-J., & Masliah, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.044 · Cited by 135
Lai, L., Song, Y., Liu, Y., Chen, Q., Han, Q., Chen, W., Pan, T., Zhang, Y., Cao, X., & Wang, Q. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445429 · Cited by 126
MiR-146a Negatively Regulates TLR2-Induced Inflammatory Responses in Keratinocytes
Meisgen, F., Xu Landén, N., Wang, A., Réthi, B., Bouez, C., Zuccolo, M., Gueniche, A., Ståhle, M., Sonkoly, E., Breton, L., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.89 · Cited by 124
Zeng, K.-W., Zhang, T., Fu, H., Liu, G.-X., & Wang, X.-M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.030 · Cited by 116 · cited 2×
“…compounds are found in the Chinese medicinal plant Schisandra chinensis and are part of the dibenzocyclooctadiene family; schizandrin A (Song et al., 2016), schizandrin B (Giridharan et al., 2012; Zeng et al., 2012), and gomosins A/G/J/N inhibit microglial production of NO, TNFα, and IL-6.”
BackgroundNon-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
Kim, C., Lee, H.-J., Masliah, E., & Lee, S.-J. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.3.113 · Cited by 92
Microglia display modest phagocytic capacity for extracellular tau oligomers
Majerova, P., Zilkova, M., Kazmerova, Z., Kovac, A., Paholikova, K., Kovacech, B., Zilka, N., & Novak, M. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0161-z · Cited by 90 · cited 1×
“This binary categorization is meant to represent the prototypical proinflammatory and antiinflammatory/phagocytic responses of microglia (Bachstetter et al., 2014; Majerova et al., 2014).”
BackgroundGabhann, J. N., Higgs, R., Brennan, K., Thomas, W., Damen, J. E., Ben Larbi, N., Krystal, G., & Jefferies, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902589 · Cited by 81 · cited 1×
“Evidence suggests SHIP1 inhibits TBK1, a member of the TRIF-dependent signaling pathway (Gabhann et al., 2010; Thounaojam et al., 2014).”
BackgroundAisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cited by
Kim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., Fields, J. A., Masliah, D., Iba, M., Lee, H.-J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0276-2 · Cited by 157
Immune Dysregulation in Children With Down Syndrome
Huggard, D., Doherty, D. G., & Molloy, E. J. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00073 · Cited by 144
“There are many regulators described for TLRs, with microRNAs (miRNAs) now being described as key controllers of signals from these receptors (87).”
BackgroundIba, M., Kim, C., Sallin, M., Kwon, S., Verma, A., Overk, C., Rissman, R. A., Sen, R., Sen, J. M., & Masliah, E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01888-0 · Cited by 120
“…also been shown to activate microglia and astrocytes via toll-like receptors (TLRs) to produce pro-inflammatory cytokines such as IL-1 β , IL-6, and TNF α [26 – 29]. α -syn is primarily a pre-synaptic protein [30] and involved in endosomal formation and vesicle release at the synapse [31 – 33].”
RetractedJiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L., Duran, W., Peterson, C., Zimmerman, A., Mandell, M. A., Jett, S. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109720 · Cited by 92
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Kwon, S., Iba, M., Masliah, E., & Kim, C. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.547 · Cited by 35
“Although TLRs have been extensively studied in the innate immune system, recent studies have also suggested a critical role for TLRs in neurodegenerative diseases such as synucleinopathies and AD [27-29].”
Background
Metadata
- Authors
- Caplan, I. F., & Maguire-Zeiss, K. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-05-04
- Volume
- 9
- Pages
- 417-417
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2796492196
- Cited by
- 63
- References
- 55
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.